ANGN

Angion Biomedica Corp

PHARMACEUTICAL PREPARATIONS
LIFE SCIENCES

Prices are adjusted according to historical splits.

Angion Biomedica Corp Stock Price

Vitals

Today's Low:
$0.9600
Today's High:
$0.9954
Open Price:
$0.9600
52W Low:
$0.87
52W High:
$5.13
Prev. Close:
$0.9748
Volume:
65324

Company Statistics

Market Cap.:
$0.029 billion
Book Value:
1.989
Revenue TTM:
$0.030 billion
Operating Margin TTM:
-72.2%
Gross Profit TTM:
$-0.021 billion
Gross Profit TTM:
$-0.021 billion
Profit Margin:
-81.5%
Return on Assets TTM:
-13.7%
Return on Equity TTM:
-35.3%

Company Profile

Angion Biomedica Corp had its IPO on 2021-02-05 under the ticker symbol ANGN.

The company operates in the LIFE SCIENCES sector and PHARMACEUTICAL PREPARATIONS industry. Angion Biomedica Corp has a staff strength of 0 employees.

Stock update

Shares of Angion Biomedica Corp opened at $0.96 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $0.96 - $1, and closed at $0.97.

This is a -0.54% slip from the previous day's closing price.

A total volume of 65,324 shares were traded at the close of the day’s session.

In the last one week, shares of Angion Biomedica Corp have slipped by -3.05%.

Angion Biomedica Corp's Key Ratios

Angion Biomedica Corp has a market cap of $0.029 billion, indicating a price to book ratio of 0.504 and a price to sales ratio of 0.983.

In the last 12-months Angion Biomedica Corp’s revenue was $0.030 billion with a gross profit of $-0.021 billion and an EBITDA of $-0.021 billion. The EBITDA ratio measures Angion Biomedica Corp's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Angion Biomedica Corp’s operating margin was -72.2% while its return on assets stood at -13.7% with a return of equity of -35.3%.

In Q2, Angion Biomedica Corp’s quarterly earnings growth was a positive 0% while revenue growth was a positive 20.9%.

Angion Biomedica Corp’s PE and PEG Ratio

Forward PE
-
Trailing PE
-
PEG
None

Its diluted EPS in the last 12-months stands at $-1.075 per share while it has a forward price to earnings multiple of - and a PEG multiple of None. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Angion Biomedica Corp’s profitability.

Angion Biomedica Corp stock is trading at a EV to sales ratio of 2.257 and a EV to EBITDA ratio of 1.224. Its price to sales ratio in the trailing 12-months stood at 0.983.

Angion Biomedica Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$0.000 billion
Total Liabilities
$0.000 billion
Operating Cash Flow
$0.000 billion
Capital Expenditure
$0.000 billion
Dividend Payout Ratio
0%

Angion Biomedica Corp ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

Angion Biomedica Corp ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

Angion Biomedica Corp’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, Angion Biomedica Corp's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, Angion Biomedica Corp paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price
$0.97
52-Week High
$5.13
52-Week Low
$0.87
Analyst Target Price
$1.5

Angion Biomedica Corp stock is currently trading at $0.97 per share. It touched a 52-week high of $5.13 and a 52-week low of $5.13. Analysts tracking the stock have a 12-month average target price of $1.5.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About Angion Biomedica Corp

The stock symbol (also called stock or share ticker) of Angion Biomedica Corp is ANGN

The IPO of Angion Biomedica Corp took place on 2021-02-05

Similar Industry Stocks (PHARMACEUTICAL PREPARATIONS)

Last Price
Chg
Chg%
$0.89
-0.02
-2.07%
$14.41
1.16
+8.75%
$6.02
-0.26
-4.14%
$6.37
-0.14
-2.15%
$0.75
-0.02
-2.04%

Most Active

Last Price
Chg
Chg%
$58.63
-1.03
-1.73%
$92.12
-4.67
-4.82%
$5.12
-0.61
-10.65%
Apple Inc (AAPL)
$145.03
-5.62
-3.73%
$0.06
0.01
+12.74%

Top Gainers

Last Price
Chg
Chg%
$73
42.7
+140.92%
Oi S.A (OIBR-C)
$0
0
+100%
$0.02
0.01
+100%
$0.25
0.1
+66.44%
$2.85
1.01
+54.86%

Top Losers

Last Price
Chg
Chg%
$5.36
-22.58
-80.82%
$0.02
-0.06
-78.67%
Air T, Inc (AIRTW)
$0.01
-0.03
-75%
$4.51
-5.17
-53.41%
$11.5
-12.2
-51.48%

About

Angion Biomedica Corp. The company is headquartered in Uniondale, New York.

Address

51 CHARLES LINDBERGH BOULEVARD, UNIONDALE, NY, US